(Q44090125)

29 November 2017

title

Optimisation of contained Nicotiana tabacum cultivation for the production of recombinant protein pharmaceuticals (English)

1 reference

29 November 2017

1 reference

Richard Colgan

1

1 reference

29 November 2017

Christopher J Atkinson

2

1 reference

29 November 2017

Matthew Paul

3

1 reference

29 November 2017

Sally Hassan

4

1 reference

29 November 2017

Pascal M W Drake

5

1 reference

29 November 2017

Amy L Sexton

6

1 reference

29 November 2017

Simon Santa-Cruz

7

1 reference

29 November 2017

David James

8

1 reference

29 November 2017

Keith Hamp

9

1 reference

29 November 2017

Colin Gutteridge

10

1 reference

29 November 2017

Julian K-C Ma

11

1 reference

29 November 2017

language of work or name

1 reference

9 July 2009

1 reference

29 November 2017

1 reference

29 November 2017

volume

19

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

241-256

1 reference

https://scigraph.springernature.com/pub.10.1007/s11248-009-9303-y

29 November 2017

exact match

0 references

cites work

Evolution of a regulatory framework for pharmaceuticals derived from genetically modified plants.

1 reference

12 December 2020

Characterization of monoclonal antibodies to Streptococcus mutans antigenic determinants I/II, I, II, and III and their serotype specificities

1 reference

12 December 2020

Characterization of the conformational epitope of Guy's 13, a monoclonal antibody that prevents Streptococcus mutans colonization in humans.

1 reference

12 December 2020

Generation and assembly of secretory antibodies in plants

1 reference

12 December 2020

Assembly of monoclonal antibodies with IgG1 and IgA heavy chain domains in transgenic tobacco plants

1 reference

12 December 2020

Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development

1 reference

12 December 2020

Transgenic plant production of Cyanovirin-N, an HIV microbicide.

1 reference

12 December 2020

Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants

1 reference

12 December 2020

A small decrease of plastid transketolase activity in antisense tobacco transformants has dramatic effects on photosynthesis and phenylpropanoid metabolism

1 reference

12 December 2020

Influence of growth conditions and developmental stage on N-glycan heterogeneity of transgenic immunoglobulin G and endogenous proteins in tobacco leaves

1 reference

12 December 2020

Considerations for extraction of monoclonal antibodies targeted to different subcellular compartments in transgenic tobacco plants.

1 reference

12 December 2020

Detection of Rubisco and mycotoxins as potential contaminants of a plantibody against the hepatitis B surface antigen purified from tobacco

1 reference

12 December 2020

Expression, purification, and characterization of recombinant cyanovirin-N for vaginal anti-HIV microbicide development

1 reference

12 December 2020

Large-scale purification of an antibody directed against hepatitis B surface antigen from transgenic tobacco plants.

1 reference

12 December 2020

Effect of climate conditions and plant developmental stage on the stability of antibodies expressed in transgenic tobacco.

1 reference

12 December 2020

Pharma-Planta: road testing the developing regulatory guidelines for plant-made pharmaceuticals

1 reference

12 December 2020

10.1007/S11248-009-9303-Y

Identifiers

DOI

1 reference

29 November 2017

1 reference